V
WST icon

Veritable’s West Pharmaceutical WST Stock Holding History

Veritable’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,364
Closed -$205K – 829
2019
Q4 		$205K Buy
+1,364
New +$199K ﹤0.01% 782
2019
Q1 		– Sell
-2,612
Closed -$256K – 822
2018
Q4 		$256K Sell
2,612
-5
-0.2% -$543 0.01% 653
2018
Q3 		$323K Sell
2,617
-795
-23% -$89.2K 0.01% 621
2018
Q2 		$339K Sell
3,412
-2,871
-46% -$264K 0.01% 601
2018
Q1 		$555K Sell
6,283
-25
-0.4% -$2.34K 0.01% 467
2017
Q4 		$622K Sell
6,308
-1,900
-23% -$186K 0.01% 452
2017
Q3 		$790K Buy
8,208
+516
+7% +$46.7K 0.02% 395
2017
Q2 		$727K Buy
7,692
+452
+6% +$41.6K 0.02% 420
2017
Q1 		$591K Sell
7,240
-381
-5% -$31.9K 0.01% 450
2016
Q4 		$646K Buy
7,621
+1,248
+20% +$98.1K 0.02% 410
2016
Q3 		$475K Buy
6,373
+1,918
+43% +$152K 0.01% 487
2016
Q2 		$338K Buy
4,455
+209
+5% +$15.2K 0.01% 537
2016
Q1 		$294K Buy
+4,246
New +$255K 0.01% 579

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Veritable's WST Position: Q1 2020 in Review

Veritable sold out of West Pharmaceutical (WST) in Q1 2020, closing a stake of 1,364 shares — an estimated $205K sold.

Veritable first reported a position in WST in Q1 2016 and held it in 13 quarters. The position peaked at $790K in Q3 2017. 468 funds tracked by Wall St. Rank hold WST as of Q1 2020.

  • Veritable reported no remaining West Pharmaceutical position as of Q1 2020 after selling out during the quarter.
  • Veritable sold 1,364 West Pharmaceutical shares in Q1 2020, an estimated $205K.
  • Veritable first reported a position in West Pharmaceutical in Q1 2016 and held it in 13 quarters.
  • Veritable's West Pharmaceutical position peaked at $790K in Q3 2017.
  • 468 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2020.

Based on Veritable's 13F filing for Q1 2020, filed 13 May 2020.